tirzepatide 2.5 mg/0.5 ml subcutaneous pen injector MOUNJARO MG / 0.5 ( ) FOR INJECTION 4 VIALS Mounjaro (Tirzepatide) Injection 5 mg/0.5

Donors should report any history of fainting, dizziness upon standing, or cardiovascular symptoms to medical staff before proceeding with donation

The fungal glutathione S-transferase system

A new study has found that gastrointestinal symptoms are the most frequently reported side effects associated with GLP-1 receptor agonist medications, including Ozempic, Wegovy, and Mounjaro

The key strategies for minimizing regain during a short break include maintaining a high protein intake of 1.6-2.2 grams per kilogram of body weight daily, continuing or increasing resistance training to preserve muscle mass, planning meals in advance so hunger does not drive impulsive food choices, monitoring weight weekly but not daily to avoid overreacting to normal fluctuations, and staying hydrated since the body may retain more water without GLP-1 mediated effects on fluid balance